NCT03006341View on ClinicalTrials.gov

Validation of Predictors of OAC Initiation Using EMR Data

CompletedOBSERVATIONAL
Enrollment

140,187

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

May 9, 2017

Study Completion Date

May 9, 2017

Conditions
Atrial Fibrillation
Interventions
DRUG

Dabigatran etexilate

observed upto 12 months

DRUG

Warfarin

Observed upto 12 months

Trial Locations (1)

02120

Brigham & Women's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03006341 - Validation of Predictors of OAC Initiation Using EMR Data | Biotech Hunter | Biotech Hunter